News

Publication in Journal of Cell Biology: SNX10 as a modulator of mitochondrial protein turnover and mitochondrial bioenergetics

Laura Trachsel-Moncho
Laura Trachsel-Moncho

Mitochondria are essential for cellular energy production and homeostasis, and their selective degradation through mitophagy is critical for maintaining cell function. However, the molecular mechanisms governing this process remain incompletely understood.

Now, Laura Trachsel-Moncho and co-workers in Anne Simonsen’s group identify the endosomal protein SNX10 as a modulator of piecemeal mitophagy, a process involving the selective degradation of mitochondrial components. They show that SNX10 localizes to early endosomes in normal conditions but associates with mitochondria-containing endosomal structures under hypoxia-mimicking stress. Loss of SNX10 leads to increased turnover of specific mitochondrial proteins, reduced mitochondrial respiration, and elevated reactive oxygen species (ROS) levels. Furthermore, zebrafish larvae lacking Snx10 exhibit reduced COX-IV levels and increased oxidative stress and cell death, demonstrating the physiological relevance of Snx10 in mitochondrial homeostasis.

These findings uncover an unexpected role for SNX10 in mitochondrial quality control and highlight its importance in cellular adaptation to metabolic stress.

Advancing the understanding of Lynch Syndrome screening and the significance of comprehensive genetic testing

Mev Dominquez Valentin
Mev Dominquez Valentin

Mev Dominquez-Valentin from the Department of Tumor Biology at the Institute for Cancer Research is senior author on a study recently published in the prestigious journal Clinical Gastroenterology and Hepatology, entitled: "Characterization of Screening Strategies for Lynch Syndrome in Latin America.” The study involves the collaborations of more than 50 investigators from 24 representative genetic cancer registries/center of 8 countries from Latin America, highlighting the significant insights we've gained into Lynch Syndrome (LS) screening methods across the region. The results emphasize challenges in hereditary cancer syndrome screening in Latin America and the need for enhanced strategies. Other OUS researchers involved in the study are Eivind Hovig, Pål Møller and Vessela Kristensen.

Mar 2025Feb 2025Dec 2024Nov 2024Oct 2024Sep 2024Jul 2024Jun 2024May 2024Apr 2024Mar 2024Feb 2024Jan 2024Dec 2023Nov 2023Oct 2023Sep 2023Aug 2023Jul 2023Jun 2023May 2023Apr 2023Mar 2023Feb 2023Jan 2023Dec 2022Nov 2022Oct 2022Sep 2022Aug 2022Jun 2022May 2022Apr 2022Mar 2022Feb 2022Dec 2021Nov 2021Oct 2021Sep 2021Aug 2021Jun 2021May 2021Apr 2021Mar 2021Feb 2021Jan 2021Dec 2020Nov 2020Oct 2020Aug 2020Jul 2020Jun 2020May 2020Apr 2020Mar 2020Feb 2020Jan 2020Dec 2019Nov 2019Oct 2019Sep 2019Aug 2019Jul 2019Jun 2019May 2019Apr 2019Feb 2019Jan 2019Dec 2018Nov 2018Oct 2018Sep 2018Aug 2018Jul 2018Jun 2018May 2018Apr 2018Mar 2018Feb 2018Jan 2018Dec 2017Nov 2017Oct 2017Sep 2017Aug 2017Jun 2017May 2017Apr 2017Mar 2017Feb 2017Jan 2017Dec 2016Nov 2016Oct 2016Sep 2016Aug 2016Jun 2016May 2016Apr 2016Mar 2016Feb 2016Jan 2016Dec 2015Oct 2015Sep 2015Aug 2015Jul 2015Jun 2015May 2015Apr 2015Mar 2015Feb 2015Jan 2015Dec 2014Nov 2014Oct 2014Sep 2014Aug 2014Jul 2014Jun 2014May 2014Apr 2014Mar 2014Feb 2014Jan 2014Dec 2013Nov 2013Oct 2013Sep 2013Aug 2013Jul 2013Jun 2013May 2013Apr 2013Mar 2013Feb 2013Jan 2013Dec 2012Nov 2012Oct 2012Sep 2012Aug 2012Jul 2012Jun 2012May 2012Apr 2012Mar 2012Feb 2012Jan 2012Dec 2011Nov 2011Oct 2011Sep 2011Aug 2011Jul 2011Jun 2011May 2011Apr 2011Mar 2011Feb 2011Jan 2011Dec 2010Nov 2010Oct 2010Sep 2010Aug 2010Jul 2010Jun 2010May 2010Apr 2010Mar 2010Feb 2010Jan 2010Dec 2009Nov 2009Oct 2009Sep 2009Aug 2009Jun 2009May 2009Apr 2009Mar 2009Feb 2009Jan 2009Dec 2008Nov 2008Oct 2008Sep 2008Aug 2008Jul 2008Jun 2008